Next, we asked whether this GDC-0339-induced reduction in day 5 tumor S100A8 and -A9 and serum S100A8/A9 levels is associated with changes in the abundance of select immune cell types in tumors, namely CD8 T cells, Tregs, and MDSCs. The gene discussed is CD8A; the disease is neoplasm.